About Lorcaserinlorcaserin.

About Lorcaserinlorcaserin, Arena orally administered, internally discovered drug candidates for the treatment of obesity is in an ongoing Phase 3 program The compound stimulates the 5-HT2C serotonin receptor in the hypothalamus, a region of. Brain with the control of satiety and metabolism associated. Showed results from a Phase 2 study, Approximately two thirds with lorcaserin produced statistically significant, progressive and dose-dependent weight loss over a 12-week period. Lorcaserin was at all doses at all doses and had no apparent effect on heart valves or pulmonary artery pressure.

About Arena PharmaceuticalsArena is a clinical-stage biopharmaceutical company, uncertainties. Development and commercialization of drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena ‘s most advanced drug candidate, lorcaserin, is Phase 3 clinical Phase 3 clinical trial for the treatment of obesity. Arena ‘s broad pipeline of novel compounds targeting G protein – coupled receptors, an important class of validated targets includes compounds evaluated independently and with its partners, Merck & Co. And Ortho-McNeil Pharmaceutical.Health care system is ‘that we do not know, a very many times, whether the most expensive treatment doing something good. The United States medical records of the U.S. Residing ‘secrets that might real improve our health, ‘but’we need to ‘to protect our privacy at the expense of for our health, because the federal government could be to misuse write writes Kinsey (Kinsley Washington Post.. ‘The time is a real moral dilemma over what happens after you defining and which goal of decent reach. ‘health care to all U.S. Citizens Washington Post a columnist Michael Kinsley writes in a commentary.

Other Posts From Category "revitalization":

Related Posts